Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Next Previous
Trial Profile

An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rotavirus W179-9 vaccine (Primary) ; Measles vaccines; Meningococcal vaccine conjugate; Yellow fever vaccine
  • Indications Rotavirus infections
  • Focus Pharmacodynamics

    • Most Recent Events

    • 12 Apr 2018 Primary endpoint (The immune response will be parameterized as the yellow fever virus neutralizing antibody seroconversion rate) has not been met as per the results published in the Journal of Infectious Diseases.
    • 12 Apr 2018 Primary endpoint (The immune response will be parameterized as the measles virus neutralizing antibody seroconversion rate) has been met as per the results published in the Journal of Infectious Diseases.
    • 12 Apr 2018 Results published in the Journal of Infectious Diseases
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top